Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky 40202, United States.
Division of Nephrology & Hypertension, Department of Medicine, University of Louisville, Louisville, Kentucky 40202, United States.
Chem Res Toxicol. 2020 Jun 15;33(6):1403-1417. doi: 10.1021/acs.chemrestox.9b00515. Epub 2020 Apr 27.
Exposure to arsenic, a class I carcinogen, affects 200 million people globally. Skin is the major target organ, but the molecular etiology of arsenic-induced skin carcinogenesis remains unclear. Arsenite (As)-induced disruption of alternative splicing could be involved, but the mechanism is unknown. Zinc finger proteins play key roles in alternative splicing. As can displace zinc (Zn) from C3H1 and C4 zinc finger motifs (zfm's), affecting protein function. ZRANB2, an alternative splicing regulator with two C4 zfm's integral to its structure and splicing function, was chosen as a candidate for this study. We hypothesized that As could displace Zn from ZRANB2, altering its structure, expression, and splicing function. As/Zn binding and mutual displacement experiments were performed with synthetic apo-peptides corresponding to each ZRANB2 zfm, employing a combination of intrinsic fluorescence, ultraviolet spectrophotometry, zinc colorimetric assay, and liquid chromatography-tandem mass spectrometry. ZRANB2 expression in HaCaT cells acutely exposed to As (0 or 5 μM, 0-72 h; or 0-5 μM, 6 h) was examined by RT-qPCR and immunoblotting. ZRANB2-dependent splicing of TRA2B mRNA, a known ZRANB2 target, was monitored by reverse transcription-polymerase chain reaction. As bound to, as well as displaced Zn from, each zfm. Also, Zn displaced As from As-bound zfm's acutely, albeit transiently. As exposure induced ZRANB2 protein expression between 3 and 24 h and at all exposures tested but not ZRANB2 mRNA expression. ZRANB2-directed TRA2B splicing was impaired between 3 and 24 h post-exposure. Furthermore, ZRANB2 splicing function was also compromised at all As exposures, starting at 100 nm. We conclude that As exposure displaces Zn from ZRANB2 zfm's, changing its structure and compromising splicing of its targets, and increases ZRANB2 protein expression as a homeostatic response both at environmental/toxicological exposures and therapeutically relevant doses.
砷暴露,一种 I 类致癌物质,影响全球 2 亿人。皮肤是主要的靶器官,但砷诱导皮肤癌发生的分子病因尚不清楚。砷酸盐(As)诱导的选择性剪接紊乱可能与之相关,但机制尚不清楚。锌指蛋白在选择性剪接中发挥关键作用。砷可以从 C3H1 和 C4 锌指模体(zfm)中置换锌,从而影响蛋白质功能。ZRANB2 是一种具有两个 C4 zfm 的选择性剪接调节因子,其结构和剪接功能完整,被选为该研究的候选者。我们假设砷可以从 ZRANB2 中置换锌,从而改变其结构、表达和剪接功能。采用内源荧光、紫外分光光度法、锌比色法和液相色谱-串联质谱联用的方法,对合成的与每个 ZRANB2 zfm 对应的脱辅基肽进行了 As/Zn 结合和相互置换实验。通过 RT-qPCR 和免疫印迹法检测急性暴露于 As(0 或 5 μM,0-72 h;或 0-5 μM,6 h)的 HaCaT 细胞中 ZRANB2 的表达。监测已知的 ZRANB2 靶标 TRA2B mRNA 的 ZRANB2 依赖性剪接,采用逆转录-聚合酶链反应。As 结合并从每个 zfm 中置换 Zn。此外,Zn 也能从急性暴露的 As 结合 zfm 中置换 As。As 暴露在 3 至 24 小时以及所有测试暴露时诱导 ZRANB2 蛋白表达,但不诱导 ZRANB2 mRNA 表达。暴露后 3 至 24 小时,ZRANB2 靶向的 TRA2B 剪接受损。此外,在所有 As 暴露时,ZRANB2 的剪接功能也受到损害,起始浓度为 100nm。我们的结论是,As 暴露从 ZRANB2 zfm 中置换锌,改变其结构并损害其靶标的剪接,同时在环境/毒理学暴露和治疗相关剂量下,作为一种体内平衡反应,还增加 ZRANB2 蛋白的表达。